Department of Medical Physics, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, 248016, India.
Department of Cardiology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, 248016, India.
Radiol Phys Technol. 2024 Jun;17(2):476-487. doi: 10.1007/s12194-024-00805-x. Epub 2024 Apr 23.
The objective of this study was to investigate patient radiation doses by a dose audit of three common interventional cardiology (IC) procedures: coronary angiography (CA), percutaneous transluminal coronary angioplasty (PTCA) and CA-PTCA procedures performed in IC centres in the Uttarakhand state of India, for the establishment of local diagnostic reference levels (DRLs) and the estimation of average effective dose (E) for these procedures. For each procedure, the values of kerma-area product (P), reference air kerma (K), fluoroscopy time (FT) and the number of cine images were recorded from 1233 CA, 458 PTCA and 736 CA-PTCA procedures performed over a 12-month period at 13 IC centres of the state. From the recorded dose data, 0.6%, 1.53% and 7.9% patients were identified to have exceeded the P trigger level of 500 Gy cm for possible skin injury for CA, PTCA and CA-PTCA procedures, respectively. The 3rd quartile of the distribution of the recorded P values for each type of procedure was calculated to estimate local DRL values. The estimated values of DRLs and E were 37, 153 and 224 Gy cm, and 6.72, 23.97 and 34.79 mSv for CA, PTCA and CA-PTCA procedures, respectively. For about 77% of the surveyed centres, the recorded patient doses were in agreement with the international standards. The local DRLs proposed in this study may be used to achieve patient dose optimization during IC procedures and the obtained patient dose data may also be archived into national dose database for the establishment of national DRLs.
本研究的目的是通过对印度北阿坎德邦(Uttarakhand)三个常见介入心脏病学(IC)程序(冠状动脉造影术(CA)、经皮腔内冠状动脉血管成形术(PTCA)和 CA-PTCA)的剂量审核,来调查患者的辐射剂量,以便为这些程序建立当地的诊断参考水平(DRLs)和估计平均有效剂量(E)。对于每种程序,从 13 个 IC 中心的 1233 例 CA、458 例 PTCA 和 736 例 CA-PTCA 程序中记录了 12 个月内的比释动能面积乘积(P)、参考空气比释动能(K)、透视时间(FT)和电影图像数量的值。从记录的剂量数据中,分别有 0.6%、1.53%和 7.9%的 CA、PTCA 和 CA-PTCA 患者的 P 值超过 500Gy·cm,这可能导致皮肤损伤。计算每种类型程序记录的 P 值分布的第 3 四分位数以估计当地的 DRL 值。估计的 DRL 值和 E 值分别为 37、153 和 224Gy·cm,6.72、23.97 和 34.79mSv,用于 CA、PTCA 和 CA-PTCA 程序。对于约 77%的调查中心,记录的患者剂量与国际标准一致。本研究提出的当地 DRL 可用于在 IC 程序中实现患者剂量优化,并且获得的患者剂量数据也可以归档到国家剂量数据库中,以建立国家 DRL。